Covered recipient · General Payments record
DAVID MABRIE
Allopathic & Osteopathic Physicians Otolaryngology Facial Plastic Surgery
General Payments · PY2018–2024
$10,771.71
- Reported across 196 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,338.84 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $711.54 | 9 |
| ABBVIE INC. | $505.16 | 24 |
| MERZ NORTH AMERICA, INC. | $90.27 | 3 |
| Galderma Laboratories, L.P. | $31.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.65 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917693 | CMS |
| ABBVIE INC. | $22.75 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917695 | CMS |
| ABBVIE INC. | $22.75 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917697 | CMS |
| ABBVIE INC. | $3.28 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917699 | CMS |
| ABBVIE INC. | $24.26 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917701 | CMS |
| ABBVIE INC. | $24.26 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917703 | CMS |
| ABBVIE INC. | $23.90 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917705 | CMS |
| ABBVIE INC. | $9.05 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917707 | CMS |
| ABBVIE INC. | $8.14 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917709 | CMS |
| ABBVIE INC. | $16.14 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917711 | CMS |
| ABBVIE INC. | $24.22 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917713 | CMS |
| ABBVIE INC. | $24.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917715 | CMS |
| ABBVIE INC. | $24.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917717 | CMS |
| ABBVIE INC. | $24.52 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917719 | CMS |
| ABBVIE INC. | $24.52 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917721 | CMS |
| ABBVIE INC. | $24.85 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917723 | CMS |
| ABBVIE INC. | $24.85 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917725 | CMS |
| ABBVIE INC. | $24.98 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917727 | CMS |
| ABBVIE INC. | $24.71 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917729 | CMS |
| ABBVIE INC. | $24.33 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917731 | CMS |
| ABBVIE INC. | $19.17 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917734 | CMS |
| ABBVIE INC. | $21.56 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917736 | CMS |
| ABBVIE INC. | $24.51 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917738 | CMS |
| ABBVIE INC. | $17.22 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917740 | CMS |
| Galderma Laboratories, L.P. | $31.87 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145314147 | CMS |
| MERZ NORTH AMERICA, INC. | $31.73 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369001 | CMS |
| MERZ NORTH AMERICA, INC. | $29.75 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369005 | CMS |
| MERZ NORTH AMERICA, INC. | $28.79 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369003 | CMS |
| REVANCE THERAPEUTICS, INC. | $78.21 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923550 | CMS |
| REVANCE THERAPEUTICS, INC. | $60.26 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923552 | CMS |
| REVANCE THERAPEUTICS, INC. | $162.39 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923554 | CMS |
| REVANCE THERAPEUTICS, INC. | $29.18 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923556 | CMS |
| REVANCE THERAPEUTICS, INC. | $54.31 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923558 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.99 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923560 | CMS |
| REVANCE THERAPEUTICS, INC. | $147.09 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923562 | CMS |
| REVANCE THERAPEUTICS, INC. | $27.89 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923564 | CMS |
| REVANCE THERAPEUTICS, INC. | $119.22 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923566 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.